Dictyostatin-1 has been found to stabilize microtubules and prohibit their
depolymerization to free tubulin. Because of these activities, the
dictyostatin compounds can be used in the treatment of a number of
diseases in which aberrant cellular proliferation occurs such as
drug-sensitive and drug-resistant cancers, autoimmune disorders, and
inflammatory diseases.